Lee Young-hoon discusses the National Growth Fund as a potential paradigm shift for Korean markets, but emphasizes a cautious outlook on semiconductors. He highlights foreign buying rotation into biotech, construction, secondary battery, and holding company stocks, particularly where domestic institutions are selling at a loss. The session focuses on supply-demand dynamics and tactical opportunities in underperforming sectors ahead of policy catalysts.
This 815 Money Talk (815머니톡) video, published May 23, 2026, features Lee Young-hoon discussing D&D Pharm, Alz Genomics, ST Pharm, ABL Bio, HD Hyundai, KCC, 028260.KS. 2 trade ideas extracted by AI with direction and confidence scoring.
Speakers: Lee Young-hoon · Tickers: D&D Pharm, Alz Genomics, ST Pharm, ABL Bio, HD Hyundai, KCC, 028260.KS